Olema Oncology, Inc. (OLMA) P/S ratio
There is no P/S ratio history on record here for Olema Oncology, Inc. (OLMA). Figures as of 18 Nov 2026, 05:16 UTC, from the company's filings with the SEC and Yahoo Finance.
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Not enough data
A history of P/S ratio needs at least 3 fiscal years; none is on record here for Olema Oncology, Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.
Olema Oncology, Inc. P/S ratio, year by year
| Fiscal year | P/S ratio | Change | Year ended | Share price at year-end |
|---|---|---|---|---|
| 2025 | — | — | $25.00 | |
| 2024 | — | — | $5.83 | |
| 2023 | — | — | $14.03 | |
| 2022 | — | — | $2.45 | |
| 2021 | — | — | $9.36 | |
| 2020 | — | — | $48.08 |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.
How to read it
It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.
Olema Oncology, Inc., figure by figure
- Olema Oncology, Inc. market cap
- Olema Oncology, Inc. revenue
- Olema Oncology, Inc. earnings
- Olema Oncology, Inc. earnings per share (EPS)
- Olema Oncology, Inc. P/E ratio
- Olema Oncology, Inc. P/B ratio
- Olema Oncology, Inc. free cash flow
- Olema Oncology, Inc. operating margin
- Olema Oncology, Inc. dividend
- Olema Oncology, Inc. shares outstanding
- Olema Oncology, Inc. total debt
- Olema Oncology, Inc. cash on hand
- Olema Oncology, Inc. total assets
- Olema Oncology, Inc. return on equity (ROE)
- Olema Oncology, Inc. return on invested capital (ROIC)
Olema Oncology, Inc. (OLMA) overview: price, valuation and scorecard
Olema Oncology, Inc. P/S ratio: questions and answers
How is Olema Oncology, Inc.'s P/S ratio calculated?
The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: P/S ratio
All stocks guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Olema Oncology, Inc. (OLMA) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/OLMA/ps-ratio
Underlying data: the company's filings with the SEC and Yahoo Finance.